1. Home ›› 
  2. Notizie ›› 
  3. Rating ›› 

***Astrazeneca, Goldman Sachs alza rating a neutral***

FACEBOOK TWITTER LINKEDIN

Astrazeneca, Goldman Sachs alza rating a neutral